Gruppo R. A.; Malan D.; Kapocsi, Judit; Nemes L.; Hay C. R. M.; Boggio L.; Chowdary P.; Tagariello G.; von Drygalski A.; Hua F.; Scaramozza M.; Arkin S.; Marzeptacog Alfa Activated Study
(2018)
Background Marzeptacog alfa (activated) (MarzAA), a new recombinant activated human factor VII (rFVIIa) variant with four amino acid substitutions, was developed to provide increased procoagulant activity and a longer ...